It is also not sensitive to endocrine therapy or HER2 therapy, so the main methods currently used for triple-negative breast cancer treatment include surgery, chemotherapy, and radiation therapy [38]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.